Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial
Nature Medicine, Published online: 29 August 2026; doi:10.1038/s41591-026-04629-7 As presented at the 2026 European Society of Cardiology Congress, use of direct oral anticoagulants together with potent P2Y12 inhibitors in patients with atrial fibrillation and acute coronary syndrome was associated with higher bleeding rates without evidence of reduced ischemic events, as compared to direct oral…
We haven't written up this one. Nature Medicine has the full story — the link below goes straight to it.
